Table 2.
Correlation coefficients between cognitive insight and demographic/clinical variables
| Variables | BCIS SR score | BCIS SC score | BCIS CI score |
|---|---|---|---|
| Age | −0.11 | 0.09 | −0.17 |
| Sex | −0.13 | 0.06 | −0.21 |
| Duration of illness | −0.11 | 0.04 | −0.14 |
| Number of relapse | −0.18 | −0.10 | −0.11 |
| Education | −0.05 | −0.22 | 0.11 |
| Marital status | −0.03 | 0.05 | −0.11 |
| Antipsychoticsa | −0.21 | −0.14 | -0.05 |
| Duration of current antipsychotic treatment | −0.04 | −0.01 | −0.03 |
| Use of concomitant medications | 0.03 | −0.01 | 0.03 |
| Manchester scale | |||
| Positive symptom score | 0.07 | −0.15 | 0.18 |
| Negative symptom score | 0.07 | 0.02 | 0.06 |
| Depression/anxiety symptom score | −0.07 | −0.07 | −0.02 |
| CDSS score | 0.12 | −0.05 | 0.16 |
Notes: Data are presented as Spearman’s rank correlation coefficients (ρ, two-tailed; for sex, marital status, antipsychotics, and the use of concomitant medications) and Pearson’s correlation coefficients (r, two-tailed; for the other variables).
a
The type of antipsychotics that patients were taking at the time of the assessment.
Abbreviations: BCIS, Beck Cognitive Insight Scale; CDSS, Calgary Depression Scale for Schizophrenia; CI, composite index; SC, self-certainty; SR, self-reflectiveness.